Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Recruiting

A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology

NCT06625203

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • Gustave Roussy Paris, France
  • Charité - Universitätsmedizin Berlin Berlin, Germany
  • Universiy Hospital Erlangen & FAU Erlangen-Nürnberg Erlangen, Germany
View Trial Details
Recruiting

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

NCT06238648

Conditions
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Siteman Cancer Center at Washington University St Louis, Missouri, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Recruiting

Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia

NCT06607419

Conditions
B-Cell Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Anhui Provincial Children's Hospital Hefei, Anhui, China
  • Fujian Children's Hospital Fuzhou, Fujian, China
  • Shanghai Children's Medical center Shanghai, Shanghai Municipality, China
  • Ningbo Women and Children's Hospital Ningbo, Zhejiang, China
View Trial Details
Recruiting

CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms

NCT06593145

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations
  • Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego - Centralny Szpital Kliniczny Warsaw, Ul. Banacha 1a, Poland
  • Uniwersyteckie Centrum Kliniczne Gdańskiego Uniwersytetu Medycznego - Katedra i Klinika Hematologii i Transplantologii Gdansk, Ul. Smoluchowskiego 17, Poland
View Trial Details
Recruiting

Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

NCT06450067

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Recruiting

A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

NCT04332822

Conditions
DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations
  • Border Medical Oncology Research Unit Albury, Australia
  • Royal Prince Alfred Hospital Camperdown, Australia
  • Coffs Harbour Coffs Harbour, Australia
  • Concord Repatriation General Hospital Concord, Australia
View all 69 locations
View Trial Details

Related conditions